212501-06-9

Upstream product

• 86-81-7 3,4,5-trimethoxy-benzaldehyde 
• 3400-22-4 4-methoxy-N-methylbenzamide 
• 212501-01-4 2-{2-[hydroxy-(3,4,5trimethoxyphenyl)methyl]-4-methoxyphenyl}-4,4-dimethyl-2-oxazoline 

Downstream Products

• 212501-13-8 4-methoxy-6-(3,4,5-trimethoxybenzoyl)benzoic acid 
• 212490-62-5 methyl 2-[(4-tert-butoxycarbonylamino)phenyl]-1,2-dihydro-6-methoxy-1-oxo-4-(3,4,5-trimethoxyphenyl)-3-isoquinolinecarboxylate 
• 212501-25-2 6-methoxy-4-(3,4,5-trimethoxyphenyl)-3-isocoumarincarboxylic acid 
• 212501-86-5 3-hydroxy-6-methoxy-1-oxo-4-(3,4,5-trimethoxy-phenyl)-isochroman-3-carboxylic acid 

Relevant academic research and scientific papers

Method of inhibiting neoplastic cells with isoquinoline derivatives

A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to isoquinoline derivatives.

Novel, potent, and selective phosphodiesterase 5 inhibitors: Synthesis and biological activities of a series of 4-aryl-1-isoquinolinone derivatives

A novel class of potent and selective phosphodiesterase 5 (PDE5) inhibitors, 4-aryl-1-isoquinolinone derivatives, which have been designed by the comparison of the structure of cGMP and a previously reported 1-arylnaphthalene lignan, was disclosed. Among